The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease

Introduction Fluid overload is one of the major characteristics and complications in patients with chronic kidney disease (CKD). N-terminal pro-brain natriuretic peptide (NT-proBNP) is related to fluid status and fluid distribution. The aim of this study is to investigate the interaction between NT-proBNP and fluid status in adverse clinical outcomes of late stages of CKD. Methods We enrolled 239 patients with CKD stages 4 +/- 5 from January 2011 to December 2011 and followed up until June 2017. Fluid status was presented as hydration status (HS) value measured by body composition monitor, while HS> 7% was defined as fluid overload. Clinical outcomes included renal outcomes (commencing dialysis and estimated glomerular filtration rate decline> 3 ml/min/1.73 m(2) /year), all-cause mortality and major adverse cardiovascular events (MACEs). Results During a mean follow-up of 3.3 +/- 2.0 years, 129(54.7%) patients commenced dialysis, 88 (37.3%) patients presented rapid renal function decline, and 48(20.3%) had MACEs or died. All patients were stratified by HS of 7% and the median of plasma NT-proBNP. The adjusted risks for commencing dialysis was significantly higher in patients with high plasma NTproBNP and HS> 7% compared to those with low plasma NT-proBNP and HS. 7%. There was a significant interaction between plasma NT-proBNP and HS in commencing dialysis (P-interaction = 0.047). Besides, patients with high plasma NT-proBNP and HS> 7% had greater risks for MACEs or all-cause mortality than others with either high plasma NTproBNP or HS>7%. Conclusion NT-proBNP and fluid overload might have a synergistic association of adverse clinical outcomes in patients with late stages of CKD.